EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Completed
Conditions studied: Pregnancy Related
In brief
The Prevention Agent Pregnancy Exposure Registry, also known as EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure) is a prospective observational cohort investigation of exposures to study agents under investigation for HIV prevention. The study population will consist of female participants who are identified as becoming pregnant during their participation in a microbicide or PrEP trial, or who have had planned exposures in pregnancy safety studies as well as their babies resulting from these pregnancies. This study will only enroll babies who have not yet reached their 1 year birth date.
Key facts
- Study ID
- NCT01209754
- Run by
- Microbicide Trials Network
- People needed
- 873
- Starts
- 2009-10-01
- Expected to finish
- 2020-05-06
- Last updated by the study team
- 2021-06-21
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
- Wits Reproductive Health Institute (WRHI) — Johannesburg, Gauteng, South Africa
- CAPRISA-The Aurum Institute — Johannesburg, Guateng, South Africa
- CAPRISA eThekwini — Durban, KwaZulu-Natal, South Africa
- Perinatal HIV Research Unit (PHRU) — Johannesburg, Soweto, South Africa
- South African MRC HIV CTU Med Research Council; Botha's Hill Clinical Research Site — Durban, South Africa
- South African MRC HIV CTU Med Research Council; Isipingo — Durban, South Africa
- South African MRC HIV CTU Med Research Council; Overport — Durban, South Africa
- South African MRC HIV CTU Med Research Council; R.K. Khan Hospital — Durban, South Africa
- South African MRC HIV CTU Med Research Council; Tongaat — Durban, South Africa
- South African MRC HIV CTU Med Research Council; Umkomaas — Durban, South Africa
- South African MRC HIV CTU Med Research Council; Verulam — Durban, South Africa
- Makerere University-Johns Hopkins University Collaboration — Kampala, Uganda
- UZ-UCSF HIV Prevention Trials Unit — Chitungwiza, Seke South, Zimbabwe
- UZ-UCSF HIV Prevention Trials Unit — Harare, Spilhaus, Zimbabwe
- UZ-UCSF HIV Prevention Trials Unit — Chitungwiza, Zengeza, Zimbabwe
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.